Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: An immunohistochemical approach

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 3, 2010, Pages 211-222

  Nakanuma, Yasuni ^a   Zen, Yoh ^b   Harada, Kenichi ^a   Ikeda, Hiroko ^a   Sato, Yasunori ^a   Uehara, Takeshi ^c   Sasaki, Motoko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Biliary tree; Cholangiocarcinoma; Cytokeratin; Immunohistochemistry; Mucin; Papillary lesion

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKERATIN 20; GELATINASE B; MATRILYSIN; MUCIN; MUCIN 1; MUCIN 2; TRANSCRIPTION FACTOR CDX2; UVOMORULIN; CADHERIN; CDX2 PROTEIN, HUMAN; CYCLIN D1; HOMEODOMAIN PROTEIN; MUC1 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN;

BILE DUCT CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; INTRADUCTAL PAPILLARY BILE DUCT NEOPLASM; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; BILE DUCT CARCINOMA; BILE DUCT TUMOR; COLLOID CARCINOMA; DISEASE COURSE; METABOLISM; PAGET NIPPLE DISEASE; PANCREAS TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; SECRETION;

ADENOCARCINOMA, MUCINOUS; BETA CATENIN; BILE DUCT NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL; CARCINOMA, PAPILLARY; CHOLANGIOCARCINOMA; CYCLIN D1; DISEASE PROGRESSION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MUCIN-1; MUCIN-2; MUCINS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHENOTYPE;

EID: 77955872759     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0158-7     Document Type: Review

References (56)

1. Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985;56:1434-45.
2. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994;18:1078-91. (Pubitemid 24337615)
3. Sakamoto E, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg. 1999;23:1038-43.
4. Goto M, Shibahara H, Tamada S, Hamada T, Oda K, Nagino M, et al. Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety. Pathol Int. 2005;55:464-70. (Pubitemid 41097846)
5. Longnecker DS, Hruban RH, Adler G, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 237-40.
6. Zamboni G, Longnecker DS, Kloppel G, Adler G, Hruban RH. Mucinous cystic neoplasm of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 234-6.
7. Chen TC, Nakanuma Y, Zen Y, Chen MF, Jan YY, Yeh TS, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651-8. (Pubitemid 32927987)
8. Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kasashima S, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333-43. (Pubitemid 44748384)
9. Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902-10. (Pubitemid 37169620)
10. Nakanuma Y, Leong ASY, Sripa B, Ponchon T, Vatanasapt V, Ishak KG. Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 173-80.
11. Nakanuma Y, Sasaki M, Ishikawa A, Tsui W, Chen TC, Huang SF. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851-61. (Pubitemid 34784668)
12. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment. J Gastroenterol Hepatol. 2002;17:1056-63. (Pubitemid 35013959)
13. Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241:703-12.
14. Adbores-Saavedra J, Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N. Carcinoma of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, et al., editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 207-14.
15. Albores-Saavedra J, Murakata L, Krueger JE, Henson DE. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89:508-15. (Pubitemid 30640097)
16. Young TH, Chen TK, Lee HS. Electronic clinical challenges and images in GI. Noninvasive and minimally invasive papillary carcinomas of the common bile duct. Gastroenterology. 2008;134:e1-3.
17. Lee SS, Kim MH, Lee SK, Jang SJ, Song MH, Kim KP, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100:783-93. (Pubitemid 38176857)
18. Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38:552-70. (Pubitemid 27426381)
19. Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008;39:1153-61.
20. Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007;27:1174-84. (Pubitemid 47543145)
21. Zen Y, Fujii T, Itatsu K, Nakamura K, Konishi F, Masuda S, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol. 2006;19:1243-54. (Pubitemid 44268195)
22. Sudo Y, Harada K, Tsuneyama K, Katayanagi K, Zen Y, Nakanuma Y. Oncocytic biliary cystadenocarcinoma is a form of intraductal oncocytic papillary neoplasm of the liver. Mod Pathol. 2001;14:1304-9. (Pubitemid 33151175)
23. Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008;39:1153-61.
24. Sasaki M, Ikeda H, Nakanuma Y. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem. 2007;42:61-110. (Pubitemid 47007727)
25. Sasaki M, Yamaguchi J, Itatsu K, Ikeda H, Nakanuma Y. Overexpression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol. 2008;215:175-83. (Pubitemid 351786036)
26. Ishikawa A, Sasaki M, Ohira S, Ohta T, Oda K, Nimura Y, et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest. 2004;84:629-38. (Pubitemid 38858472)
27. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer J, Poustka A, et al. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int. 2004;24:29-37.
28. Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006;30:1561-9. (Pubitemid 44808792)
29. Terada T, Nakanuma Y, Kakita A. Pathologic observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. Heterotopic pancreas in the liver. Gastroenterology. 1990;98:1333-7.
30. Terada T, Nakanuma Y. Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical analyses. Lab Invest. 1993;68:261-9.
31. Terada T, Nakanuma Y. Expression of pancreatic enzymes (alpha-amylase, trypsinogen, and lipase) during human liver development and maturation. Gastroenterology. 1995;108:1236-45.
32. Dumas A, Thung SN, Lin CS. Diffuse hyperplasia of the peribiliary glands. Arch Pathol Lab Med. 1998;122:87-9. (Pubitemid 28212614)
33. Nakanuma Y, Sasaki M, Terada T, Harada K. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol. 1994;9:80-6. (Pubitemid 24041954)
34. Terada T, Nakanuma Y. Pathologic observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers: IV. Hyperplasia of intramural and extramural glands. Hum Pathol. 1992;23:483-90.
35. Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct - an immunohistochemical study of 110 cases of hepatolithiasis. J. Hepatol. 2006;44:350-8. (Pubitemid 43069217)
36. Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20:701-9. (Pubitemid 46788877)
37. Itatsu K, Fujii T, Sasaki M, Zen Y, Nakanuma Y. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma. Hepatogastroenterology. 2007;54:677-80. (Pubitemid 46903700)
38. Ishikawa A, Sasaki M, Sato Y, Ohira S, Chen MF, Huang SF, et al. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. Hum Pathol. 2004;35:1505-14. (Pubitemid 40017991)
39. Momoi H, Itoh T, Nozaki Y, Arima Y, Okabe H, Satoh S, et al. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. J Hepatol. 2001;35:235-44. (Pubitemid 32803479)
40. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-12. (Pubitemid 28425575)
41. Tokumoto N, Ikeda S, Ishizaki Y, Kurihara T, Ozaki S, Iseki M, et al. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. Int J Oncol. 2005;27:973-80.
42. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP. Change in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005;41:365-79. (Pubitemid 40187207)
43. DeHaan RD, Kipp BR, Smyrk TC, Abraham SC, Roberts LR, Halling KC. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. Hum Pathol. 2007;38:491-9. (Pubitemid 46227534)
44. Abraham SC, Lee JH, Boitnott JK, Argani P, Furth EE, Wu TT. Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol. 2002;15:1309-17. (Pubitemid 35462999)
45. Amaya S, Sasaki M, Watanabe Y, Tsui WM, Tsuneyama K, Harada K, et al. Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis. Histopathology. 2001;38:550-60. (Pubitemid 32863008)
46. Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology. 1996;24:1074-8. (Pubitemid 26365906)
47. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-95.
48. Ashida K, Terada T, Kitamura Y, Kaibara N. Expression of Ecadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology. 1998;27:974-82. (Pubitemid 28160482)
49. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW. Downregulation and abnormal expression of E-cadherin and betacatenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol. 1999;30:458-66. (Pubitemid 29177827)
50. Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology. 1996;23:1341-4. (Pubitemid 26181214)
51. Miwa S, Miyagawa S, Soeda J, Kawasaki S. Matrix metalloproteinase- 7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer. 2002;94:428-34. (Pubitemid 34081373)
52. Sato M, Watanabe Y, Tokui K, Kohtani T, Nakata Y, Chen Y, et al. Hepatobiliary cystadenocarcinoma connected to the hepatic duct: a case report and review of the literature. Hepatogastroenterology. 2003;50:1621-4. (Pubitemid 37186545)
53. Portman BC, Nakanuma Y. Diseases of bile ducts. In: Burt AD, Portman BC, Ferrell LD, editors. MacSween's pathology of the liver. 5.th ed. London: Churchill Livingstone; 2006. p. 517-81.
54. Terada T, Nakanuma Y. Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. II. A possible source of cholangiocarcinoma. Hepatology. 1990;12:92-7.
55. Zen Y, Terahata S, Miyayama S, Mitsui T, Takehara A, Miura S, et al. Multicystic biliary hamartoma: a hitherto undescribed lesion. Hum Pathol. 2006;37:339-44. (Pubitemid 43277522)
56. Fujii T, Harada K, Katayanagi K, Kurumaya H, Nakanuma Y. Intrahepatic cholangiocarcinoma with multicystic, mucinous appearance and oncocytic change. Pathol Int. 2005;55:206-9. (Pubitemid 40676930)